Description
The active ingredient in Lasonil Heparinoid Pomadei is heparinoid. This substance forms the core of the medication’s therapeutic effects. Produced by Bayer Türk Kimya San. Tic. Ltd. Şti, Lasonil harnesses the potential of heparinoid to address specific medical conditions.
Indications
Lasonil Pomadei is designed for the local treatment of closed injuries, whether they involve hematomas or not. This includes a range of conditions such as sprains, bruises, joint effusions, and swelling. Additionally, Lasonil finds utility in the local treatment of superficial phlebitis, particularly cases that cannot be effectively managed with compression.
Contraindications
Individuals who exhibit hypersensitivity to heparin or heparinoids should refrain from using Lasonil. Prior to application, it is imperative to ascertain whether any such hypersensitivity exists.
Warnings and Precautions
To ensure the safe and effective use of Lasonil, several precautions should be observed. It is not suitable for cases involving bleeding and should not be applied to open wounds or areas with infections. Careful adherence to these precautions is vital.
Side Effects
Lasonil is generally well-tolerated by individuals. In rare instances, it may lead to skin redness. It’s noteworthy that this side effect typically subsides upon discontinuation of the medication. Users should be aware of this possibility but also understand its infrequent occurrence.
Interactions
Lasonil may interact with other medications, potentially affecting their efficacy or safety. Notable interactions include cardiac glycosides, glucocorticoids, laxatives, carbenoxolone, nephrotoxic antibiotics, salicylates, diuretics, lithium, aminoglycoside class antibiotics, pressor amines (e.g., adrenaline, noradrenaline), and muscle relaxants. Users should consult with healthcare professionals to ensure their safety when combining medications.
Application
The application of Lasonil Pomadei is straightforward. It involves topical application to the injured area, followed by gentle massage. The duration of use varies based on the condition being treated. For blunt injuries, it is typically applied for around 10 days. In cases of superficial phlebitis, a treatment period of 1-2 weeks is common. For hematomas, larger quantities of Lasonil pomade are massaged into the affected area.
Availability
As of August 30, 2023, it’s important to note that Lasonil was not listed on the Australian Register of Therapeutic Goods (ARTG). Availability of pharmaceuticals can vary by country and local regulations. Therefore, individuals seeking Lasonil should consult local pharmacies or healthcare professionals to determine its accessibility.
How Lasonil Heparinoid Pomadei Works
Lasonil Heparinoid Pomadei operates by preventing the formation of small blood clots just beneath the skin. Simultaneously, it reduces swelling in veins, leading to several benefits:
- Alleviation of pain
- Improved circulation in small blood vessels beneath the skin
- Accelerated healing of bruises
- Reduced inflammation of veins, particularly superficial thrombophlebitis
This mechanism of action underscores Lasonil’s effectiveness in addressing various medical conditions.
Dosage
The appropriate dosage of Lasonil Heparinoid Pomadei hinges on the specific condition being treated. For closed injuries, including those with hematomas, such as sprains, bruises, joint effusions, and swelling, the application is topical, with light massage, over a period of approximately 10 days.
In cases of superficial phlebitis that cannot be managed with compression, the application extends to 1-2 weeks. For hematomas, larger quantities of Lasonil pomade are gently massaged into the affected area. Users are strongly advised to adhere to the guidance of healthcare professionals regarding dosage and duration of use.
Pregnancy and Breastfeeding
Lasonil Heparinoid Pomadei is generally considered safe for use during pregnancy and breastfeeding. However, it is prudent to consult with a healthcare provider or pharmacist before use. The likelihood of the medication entering breast milk is very low. When applying the cream or gel, care should be taken to prevent the baby from coming into contact with the treated areas. Handwashing after application is advised.
In cases where the baby’s feeding patterns or any other concerns arise, consultation with a healthcare professional, doctor, pharmacist, health visitor, or midwife is recommended.
Over the Counter or Prescription?
Heparinoid, the active ingredient in Lasonil Heparinoid Pomadei, is available both over the counter and by prescription from pharmacies and shops. Availability may vary depending on the country and its regulations. To ascertain the accessibility of Lasonil, individuals are encouraged to consult local pharmacies or healthcare professionals.
Conclusion
Lasonil Heparinoid Pomadei represents a valuable pharmaceutical resource for individuals experiencing closed injuries, including those with hematomas, and superficial phlebitis. Its effectiveness, coupled with a favorable safety profile during pregnancy and breastfeeding, underscores its utility. However, users should exercise caution, adhere to recommended dosages, and consult healthcare professionals for personalized guidance.
It is important to note that the information presented here serves as an overview, and for comprehensive details, consultation with healthcare experts is essential.
At a glance
| Property | Details |
|---|---|
| Active Ingredient | Heparinoid |
| Manufacturer | Bayer Türk Kimya San. Tic. Ltd. Şti |
| Indications | Closed Injuries with or without Hematomas, Superficial Phlebitis |
| Contraindications | Hypersensitivity to Heparin or Heparinoids |
| Side Effects | Skin Redness (Rare) |
| Interactions | Cardiac Glycosides, Glucocorticoids, Laxatives, and more |
| Application | Topical Application and Light Massage |
| Availability | Not Listed on the Australian Register of Therapeutic Goods (ARTG) as of August 30, 2023 |
Reviews
There are no reviews yet.